COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Arkansas patients with a documented clinical need may be eligible for a compounded version from a licensed pharmacy.
Arkansas has among the highest rates of diabetes and obesity in the nation, making access to GLP-1 medications particularly relevant. Compounding Finder helps Arkansas residents connect with licensed compounding pharmacies that deliver statewide.
Compounded tirzepatide is prepared by licensed compounding pharmacies using the same active pharmaceutical ingredient found in FDA-approved Mounjaro and Zepbound. Compounded versions can be customized with dose flexibility, alternative forms, and excipient adjustments.
Yes. The Arkansas State Board of Pharmacy oversees in-state compounding. A valid prescription with clinical justification is required. Cost alone does not qualify for compounding.
Typically $150 to $450 per month depending on dosage, form, and pharmacy.
.png){kind=spacer}
